Apr 16, 2026
When we look at the graph showing the number of concessions granted each month it does appear to have a series of concession cycles, with the first one starting in 2017, the second in 2022 and the third starting at the end of 2025. Therefore, we thought we’d compare...
Apr 16, 2026
Here is a product that the market seems to have abandoned. In February the average market price for this product was £134.69 per pack, the Drug Tariff was £86.80, and it had a concession of £123.63. The more ‘normal’ price between periods of shortage has...
Mar 13, 2026
When a product is in seriously short supply, Pharmacies will get their hands on any stock they can to satisfy their customers. This sometimes means that they have to get short dated stock. If they have no long dated alternative, short dated will have to do. The...
Mar 9, 2026
Here at WaveData we keep a close eye on the number of concessions granted to individual products each month and have been doing so since they were launched in November 2010. We have always assumed the Category M is the primary source of concessions and of the linked...
Mar 5, 2026
There has been a lot of discussion about Category H at recent events, online and on socials. Charles Joynson, WaveData MD, poses the question; ‘Will it cut another group of generics to the bone and seriously damage pharmacy and supplier profitability? Or will it...
Feb 16, 2026
We know that pharmacies buying generics are making a loss when they dispense. Previous analysis, available on the Wavedata.co.uk articles page, shows that over 1200 generic products each month are unprofitable. However, what about parallel imports, are they profitable...
